Skip to content
10-K

Annual Report

Jade Biosciences, Inc. JBIO

0001193125-26-096550

← back to feed
Filed
Mar 6, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 28, 2026 49.32M sh
Shares Diluted FY 2025 · Dec 31, 2025 31.36M sh
Shares Diluted FY 2025 · Dec 31, 2024 3.16M sh
Capex FY 2025 · Dec 31, 2025 $196K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$94.69M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$22.61M
Short Term Investments FY 2025 · Dec 31, 2025 $247.72M
Short Term Investments restated FY 2025 · Dec 31, 2024 $0
Cash And Equivalents FY 2025 · Dec 31, 2025 $88.44M
Cash And Equivalents restated FY 2025 · Dec 31, 2024 $69.39M
Stockholders Equity FY 2025 · Dec 31, 2025 $332.52M
Stockholders Equity restated FY 2025 · Dec 31, 2024 −$46.8M
Stockholders Equity FY 2025 · Jun 17, 2024 $1K
Current Liabilities FY 2025 · Dec 31, 2025 $16.54M
Current Liabilities restated FY 2025 · Dec 31, 2024 $12M
Total Liabilities FY 2025 · Dec 31, 2025 $17.26M
Total Liabilities restated FY 2025 · Dec 31, 2024 $119.6M
Current Assets FY 2025 · Dec 31, 2025 $348.82M
Current Assets restated FY 2025 · Dec 31, 2024 $69.65M
Total Assets FY 2025 · Dec 31, 2025 $349.78M
Total Assets restated FY 2025 · Dec 31, 2024 $72.8M
Eps Diluted FY 2025 · Dec 31, 2025 −$3.19
Eps Diluted FY 2025 · Dec 31, 2024 −$14.89
Eps Basic FY 2025 · Dec 31, 2025 −$3.19
Eps Basic FY 2025 · Dec 31, 2024 −$14.89
Sga Expense FY 2025 · Dec 31, 2025 $20.42M
Sga Expense FY 2025 · Dec 31, 2024 $4.3M
Rd Expense FY 2025 · Dec 31, 2025 $93.12M
Rd Expense FY 2025 · Dec 31, 2024 $31.23M
Net Income FY 2025 · Dec 31, 2025 −$127.41M
Net Income FY 2025 · Dec 31, 2024 −$46.98M
Operating Income FY 2025 · Dec 31, 2025 −$113.54M
Operating Income FY 2025 · Dec 31, 2024 −$35.54M